Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Zentralblatt Fur Gynakologie|January 1, 1978
[Influence of different obstetric-manipulations on the continuous measured pO2-tension upon the fetus sub partu (author's transl)]R Grosspietzsch, W Husstedt, L von Klitzing, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 1, 1982
The transcutaneous PO2 measurement as an additional evaluation index to the physiological and pathological conditions under deliveryF Klink, W Husstedt, L von Klitzing, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomataG Emons, G S Pahwa, C Brack, et al.
Zentralblatt Fur Gynakologie|January 1, 1988
[Puncture of the chorionic villi. Technic--experiences--risks]U Froster-Iskenius, F Klink, G Grzejszczyk, et al.
Fortschritte Der Medizin|June 9, 1977
[Continuous intrauterine pO2 determination in the fetus during birth]F Klink, R Grosspietzsch, W Endell, et al.
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1992
Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GnRH-agonists in ovarian cancerG Emons, O Ortmann, G S Pahwa, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
LHRH-receptors and LHRH-agonist treatment in ovarian cancer: an overviewG Emons, G S Pahwa, O Ortmann, et al.
Geburtshilfe Und Frauenheilkunde|January 1, 1985
[Radiotherapy of vulvar cancer. Treatment results of electron therapy in 446 patients 1956 to 1978]H J Frischbier, K Thomsen, H J Schmermund, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 1992
[In vivo and in vitro effects of GnRH analogs on ovarian Leydig cell tumor]G Emons, O Ortmann, G S Pahwa, et al.
Cancer|October 1, 1996
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study GroupG Emons, O Ortmann, H M Teichert, et al.
Pageof 4